Cover Image

A combination of broad neutralizing antibodies efficiently protects from in vitro cell-associated SHIV162P3 transmission

Saved in:

Bibliographic Details
Main Authors:	Karunasinee Suphaphiphat (Author), Monica Tolazzi (Author), Céline Gommet (Author), Nathalie Bosquet (Author), Gabriella Scarlatti (Author), Roger Le Grand (Author), Mariangela Cavarelli (Author)
Format:	Book
Published:	Elsevier, 2018-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A combination of broadly neutralizing antibodies prevents in vitro SHIV162p3 cell-free transmission more efficiently than cell to cell transmission
by: K. Suphaphiphat, et al.
Published: (2016)

The importance of semen leukocytes in HIV-1 transmission and the development of prevention strategies
by: Mariangela Cavarelli, et al.
Published: (2020)

Broadly neutraliing antibody cocktail prevents the establishment of viral reservoir against a mixed SHIV challenge
by: P.-T. Liu, et al.
Published: (2017)

Broadly neutralizing antibodies in HIV-1 treatment and prevention
by: Rajesh Kumar, et al.
Published: (2018)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
by: David A. Spencer, et al.
Published: (2021)

Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV
by: Sarah B. Lloyd, et al.
Published: (2017)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
by: Hursch Patel, et al.
Published: (2023)

7 Presence of HIV-1C broadly neutralizing antibodies in pregnancy and at delivery
by: T. Mduluza, et al.
Published: (2016)

PP 8.12 - 00179 In Vitro Assay for Escape Pathways from Broadly Neutralizing Antibodies
by: T. Murphy, et al.
Published: (2022)

PP 8.8 - 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
by: S. De Taeye, et al.
Published: (2022)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
by: Bei Wang, et al.
Published: (2021)

Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice
by: Yme U. van der Velden, et al.
Published: (2020)

A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.
by: Mélissanne de Wispelaere, et al.
Published: (2015)

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
by: Gwo-Yu Chuang, et al.
Published: (2020)

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
by: Zhiyin An, et al.
Published: (2023)

A polyvalent coral snake antivenom with broad neutralization capacity.
by: María Carlina Castillo-Beltrán, et al.
Published: (2019)

Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies
by: J.L. Nordstrom, et al.
Published: (2015)

Tandem bispecific antibody prevents fully and induces prolonged T cell immunity against pathogenic SHIV in monkey models
by: M. Niu, et al.
Published: (2019)

Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients
by: Yuki Higashimoto, et al.
Published: (2022)

Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation
by: Chunying Liu, et al.
Published: (2022)

Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil.
by: Alex Pauvolid-Corrêa, et al.
Published: (2017)

Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?
by: Marc H V Van Regenmortel
Published: (2015)

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV
by: Bryan T. Mayer, et al.
Published: (2024)

Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/WyethTM)
by: Mauro César da Silva, et al.
Published: (2023)

OP 6.6 - 00134 Viral Suppression in SHIV-infected Rhesus Macaques following AAVmediated Delivery of Closer-to-germline Monoclonal Antibodies
by: J. Martinez-Navio, et al.
Published: (2022)

THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
by: B.I. Bursagova, et al.
Published: (2011)

THE PROBLEM OF NEUTRALIZING ANTIBODIES IN MANAGEMENT OF MULTIPLE SCLEROSIS
by: B.I. Bursagova, et al.
Published: (2011)

High Transferability of Neutralizing Antibodies against SARS-CoV-2 to Umbilical Cord Blood in Pregnant Women Vaccinated with BNT162b2 XBB.1.5: A Retrospective Cohort Study
by: Takuma Hayashi, et al.
Published: (2024)

Novel SHIVs encoding transmitted/founder envs for latency and cure research
by: K. Bar, et al.
Published: (2017)

Novel SHIVs encoding transmitted/founder Envs for latency and cure research
by: A. Bauer, et al.
Published: (2019)

OA2-4 Enhancing HIV-1 virion tethering by BST2/tetherin sensitizes productively and latently infected T cells to ADCC mediated by broadly neutralizing anti-HIV antibodies
by: T.N.Q. Pham, et al.
Published: (2016)

Modulated production of endogenous anti-HIV broadly neutralising antibodies
by: Y. Gao, et al.
Published: (2019)

Strategies to induce broadly protective antibody responses to viral glycoproteins
by: F Krammer
Published: (2017)

Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift
by: Adrien Laroche, et al.
Published: (2022)

Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents
by: Amy D. Gelinas, et al.
Published: (2023)

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
by: Angela J. Okragly, et al.
Published: (2023)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
by: Zeqi Zhou, et al.
Published: (2021)

Potential role for neutralizing antibodies in HIV-1 infection
by: J. Mascola
Published: (2015)

Effector mechanisms of influenza-specific antibodies: neutralization and beyond
by: Federica Sicca, et al.
Published: (2018)

SARS-CoV-2 S-RBD IgG & Neutralizing antibodies among different categories of health care workers post third dose BNT162b2 mRNA COVID-19 vaccine
by: Wan Muhammad Azfar Wan Shuaib, et al.
Published: (2023)